Beyfortus 100 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F13MV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,755
Award facts
- Contract value 100% obligated
- $18,755.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,755.31 by the Defense Logistics Agency (DLA) on January 7, 2026, for the supply of Beyfortus 100 mg/ml syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 8, 2026, and was awarded on a competitive, non-set-aside basis. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the primary IDC with DLA. The parent company, Cencora, maintains a significant $999,999,999.00 IDC with the DLA through December 31, 2031, enabling the supply of a broad range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in fulfilling competitive procurement requirements for critical pharmaceutical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F13MV?
SPE2DR26F13MV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F13MV worth?
The government has obligated $18,755 on SPE2DR26F13MV.
Is contract SPE2DR26F13MV an order under another contract?
Yes. SPE2DR26F13MV is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13MV competed?
The extent of competition for SPE2DR26F13MV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award